Journal of Clinical Endocrinology & Metabolism, Vol 46, 947-951, Copyright © 1978 by Endocrine Society

ARTICLES

Plasma concentrations of prostaglandins during late human pregnancy: influence of normal and preterm labor

MD Mitchell, AP Flint, J Bibby, J Brunt, JM Arnold, AB Anderson and AC Turnbull

Highly sensitive and specific RIA procedures have been used to measure prostaglandin concentrations in the peripheral circulation of late pregnant and parturient women. The concentrations of prostaglandin E (PGE) and prostaglandin F (PGF) in plasma samples assayed within 4 weeks of collection were not significantly different among the groups studied, the levels (mean +/- SEM, picograms per ml) were: late pregnancy (n = 13): PGE, 4.8 +/- 1.0; PGF, 6.2 +/- 0.5; early term labor (n = 5): PGE, 6.8 +/- 1.5; PGF, 7.9 +/- 0.7; late term labor (n = 5): PGE, 5.4 +/- 2.2; PGF, 12.4 +/- 3.5; and preterm labor (n = 7): PGE, 4.4 +/- 0.4; PGF, 6.9 +/- 1.4. The concentration of 13,14-dihydro- 15-keto-prostaglandin F (PGFM) in late pregnancy was 59.0 +/- 7.8 pg/ml. During spontaneous term labor, the concentration of PGFM was significantly elevated (P less than 0.01) to 142.8 +/- 32.3 pg/ml in early labor and 282.7 +/- 55.3 pg/ml in late labor. The concentration of PGFM in plasma from patients in preterm labor (62.7 +/- 17.4 pg/ml) was not significantly different from that found during late pregnancy, but was significantly lower than levels found at term during early labor (P less than 0.05). The concentration of PGE increased significantly in frozen plasma samples stored for more than 4 weeks in all groups studied; the concentration of PGF was significantly elevated after storage only in the late pregnancy group (P less than 0.01). The plasma concentration of PGFM in all groups studied was unaffected by storage. It is concluded that measurement of PGFM concentrations is the most reliable method available of monitoring prostaglandins in the peripheral circulation and that great care must be exercised in the assay and interpretation of prostaglandin levels in human plasma.

This article has been cited by other articles:

				D. M. Olson The Promise of Prostaglandins: Have They Fulfilled Their Potential as Therapeutic Targets for the Delay of Preterm Birth? Reproductive Sciences, October 1, 2005; 12(7): 466 - 478. [Abstract] [PDF]

				E. B. E. Berry, J. A. Keelan, R. J. A. Helliwell, R. S. Gilmour, and M. D. Mitchell Nanomolar and Micromolar Effects of 15-Deoxy-{Delta}12,14-prostaglandin J2 on Amnion-Derived WISH Epithelial Cells: Differential Roles of Peroxisome Proliferator-Activated Receptors {gamma} and {delta} and Nuclear Factor {kappa}B Mol. Pharmacol., July 1, 2005; 68(1): 169 - 178. [Abstract] [Full Text] [PDF]

				W. X. Wu, X. H. Ma, T. Yoshizato, N. Shinozuka, and P. W. Nathanielsz Increase in Prostaglandin H Synthase 2, but Not Prostaglandin F2{alpha} Synthase mRNA in Intrauterine Tissues During Betamethasone-Induced Premature Labor and Spontaneous Term Labor in Sheep Reproductive Sciences, April 1, 2001; 8(2): 69 - 76. [Abstract] [PDF]

				J. E. Mijovic, T. Zakar, T. K. Nairn, and D. M. Olson Prostaglandin Endoperoxide H Synthase (PGHS) Activity and PGHS-1 and -2 Messenger Ribonucleic Acid Abundance in Human Chorion Throughout Gestation and With Preterm Labor J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1358 - 1367. [Abstract] [Full Text]